Results 181 to 190 of about 104,177 (305)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 654-666, October 2025.
ABSTRACT Background Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy.
Eugene Jeong   +5 more
wiley   +1 more source

The Prevalence and Drug Susceptibility of <i>Candida</i> Species and an Analysis of Risk Factors for Oral Candidiasis-A Retrospective Study. [PDF]

open access: yesAntibiotics (Basel)
Tkaczyk M   +6 more
europepmc   +1 more source

Diagnosing Invasive Candidiasis

open access: yesJournal of Clinical Microbiology, 2018
C. Clancy, M. Nguyen
semanticscholar   +1 more source

Treatment‐Refractory Tracheobronchitis in Crohn's Disease: A Rare Pulmonary Manifestation of Inflammatory Bowel Disease

open access: yesRespirology Case Reports, Volume 13, Issue 10, October 2025.
In this report, we present a case of tracheobronchitis in Crohn's disease presenting with a chronic productive cough while on infliximab. The diagnosis was made on bronchoscopy, which revealed inflammation of the trachea and main bronchi, with biopsies demonstrating squamous cell metaplasia consistent with pulmonary inflammatory bowel disease ...
Gabriel Gurieff   +4 more
wiley   +1 more source

Nanozymes in Reactive Oxygen Species‐Dependent Diseases: From Design and Preclinical Studies to Clinical Translation Prospects

open access: yesSmall Structures, Volume 6, Issue 10, October 2025.
Nanozymes emerge as promising therapeutic agents for reactive oxygen species (ROS)‐dependent diseases, offering advantages over traditional biocatalysts through enhanced stability, tunability, and targeting capabilities. This review explores their mechanisms, design strategies, and clinical progress, emphasizing precision medicine potential.
Lihong Zhou   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy